Serum free light chain analysis

被引：33

作者：

Davids, Matthew S. ^{[1
,2
]}

Murali, Mandakolathur R. ^{[2
,3
]}

Kuter, David J. ^{[1
,2
]}

机构：

[1] Massachusetts Gen Hosp, Ctr Hematol, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[3] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2010年 / 85卷 / 10期

关键词：

INDEPENDENT RISK-FACTOR; MONOCLONAL GAMMOPATHY; PROGRESSION; URINE; RATIO; IMMUNOFIXATION; AMYLOIDOSIS; REDUCTION; SURVIVAL; MARKERS;

D O I：

10.1002/ajh.21815

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In a variety of hematologic malignancies, immunoglobulin light chains (LC) are overproduced clonally and circulate without being linked by disulphide bonds to the immunoglobulin heavy chain. The recent development of a robust assay known as kappa and gamma "free'' LC (FLC) to quantify the levels of these unbound LC in the serum, and thereby determine their ratio, has led to an explosion of studies that demonstrate its utility in a wide range of hematologic disorders. This article summarizes laboratory testing for serum FLC, with a particular focus on clinical applications for the test. Am. J. Hematol. 85:787-790, 2010. (C) 2010 Wiley-Liss, Inc.

引用

页码：787 / 790

页数：4

共 50 条

[31] Serum free light chain assessment in monoclonal gammopathy and kidney disease
Hutchison, Colin A.
Basnayake, Kolitha
Cockwell, Paul
NATURE REVIEWS NEPHROLOGY, 2009, 5 (11) : 621 - 627
[32] Serum free light chain analysis: persisting limitations with new kids on the block
Van Hoovels, Lieve
Vercammen, Martine
Nevejan, Louis
Cornette, Margot
Briers, Pieter-Jan
Deeren, Dries
Van Droogenbroeck, Jan
Fostier, Karel
De Smet, Dieter
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (09) : 1440 - 1448
[33] Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis
Halushka, Marc K.
Eng, George
Collins, A. Bernard
Judge, Daniel P.
Semigran, Marc J.
Stone, James R.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2015, 8 (04) : 264 - 268
[34] Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia
Pratt, Guy
Harding, Stephen
Holder, Roger
Fegan, Chris
Pepper, Chris
Oscier, David
Gardiner, Anne
Bradwell, Arthur R.
Mead, Graham
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (02) : 217 - 222
[35] Analytical issues of serum free light chain assays and the relative performance of polyclonal and monoclonal based reagents
Carr-Smith, Hugh D.
Jenner, Ellen L.
Evans, Josie A. R.
Harding, Stephen J.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (06) : 997 - 1003
[36] Serum-free light-chain assay: clinical utility and limitations
Bhole, Malini V.
Sadler, Ross
Ramasamy, Karthik
ANNALS OF CLINICAL BIOCHEMISTRY, 2014, 51 (05) : 528 - 542
[37] Method comparison of four clinically available assays for serum free light chain analysis
Fleming, Cherina K. A.
Swarttouw, Tim
Angelino, Corrie M. de Kat
Jacobs, Joannes F. M.
Russcher, Henk
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (01) : 85 - 94
[38] The value of serum free light chain assay in patients with monoclonal gammopathies and renal failure
Luisa Campos, M.
Barbosa de Carvalho, Nuno M.
Martin-Reyes, Guillermo
NEFROLOGIA, 2012, 32 (01): : 15 - 19
[39] Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests
Heaney, Jennifer L. J.
Campbell, John P.
Griffin, Anne E.
Birtwistle, Jane
Shemar, Meena
Child, J. Anthony
Gregory, Walter M.
Cairns, David A.
Morgan, Gareth
Jackson, Graham
Drayson, Mark T.
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (02) : 220 - 230
[40] Serum Free Light Chain Quantification Testing: Comparison of Two Methods for Disease Monitoring
Singh, Gurmukh
Whitaker, Brooke M.
Wu, Alan H. B.
Xu, Hongyan
Bollag, Roni J.
JOURNAL OF APPLIED LABORATORY MEDICINE, 2022, 7 (06) : 1290 - 1301

← 1 2 3 4 5 →